These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31829826)

  • 1. Comparisons of global tests on intersection hypotheses and their application in matched parallel gatekeeping procedures.
    Ouyang J; Zhang P; Carroll KJ; Lee J; Koch G
    J Biopharm Stat; 2020 Jul; 30(4):593-606. PubMed ID: 31829826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An enhanced mixture method for constructing gatekeeping procedures in clinical trials.
    Kordzakhia G; Brechenmacher T; Ishida E; Dmitrienko A; Zheng WW; Li DF
    J Biopharm Stat; 2018; 28(1):113-128. PubMed ID: 29239689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The application of enhanced parallel gatekeeping strategies.
    Chen X; Luo X; Capizzi T
    Stat Med; 2005 May; 24(9):1385-97. PubMed ID: 15568191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of multiple intersection-union tests for multiple endpoints in combination therapy trials.
    Westfall PH; Ho SY; Prillaman BA
    J Biopharm Stat; 2001; 11(3):125-38. PubMed ID: 11725927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-arm noninferiority trials with a prespecified margin for inference of the difference in the proportions of binary endpoints.
    Hida E; Tango T
    J Biopharm Stat; 2013; 23(4):774-89. PubMed ID: 23799810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel test to compare two treatments based on endpoints involving both nonfatal and fatal events.
    Potthoff RF; Halabi S
    Pharm Stat; 2015; 14(4):273-83. PubMed ID: 25894200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of duloxetine: a comprehensive summary of results from MMRM and LOCF_ANCOVA in eight clinical trials.
    Mallinckrodt CH; Raskin J; Wohlreich MM; Watkin JG; Detke MJ
    BMC Psychiatry; 2004 Sep; 4():26. PubMed ID: 15355546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixture-based gatekeeping procedures in adaptive clinical trials.
    Kordzakhia G; Dmitrienko A; Ishida E
    J Biopharm Stat; 2018; 28(1):129-145. PubMed ID: 29283310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Time-to-First Event and Recurrent-Event Methods in Randomized Clinical Trials.
    Claggett B; Pocock S; Wei LJ; Pfeffer MA; McMurray JJV; Solomon SD
    Circulation; 2018 Aug; 138(6):570-577. PubMed ID: 29588314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gatekeeping strategies for clinical trials that do not require all primary effects to be significant.
    Dmitrienko A; Offen WW; Westfall PH
    Stat Med; 2003 Aug; 22(15):2387-400. PubMed ID: 12872297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixture-based gatekeeping procedures for multiplicity problems with multiple sequences of hypotheses.
    Dmitrienko A; Kordzakhia G; Brechenmacher T
    J Biopharm Stat; 2016; 26(4):758-80. PubMed ID: 26247744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fallback tests in dose-response clinical trials.
    Dmitrienko A; Wiens B; Westfall P
    J Biopharm Stat; 2006; 16(5):745-55. PubMed ID: 17037269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stepwise gatekeeping procedures in clinical trial applications.
    Dmitrienko A; Tamhane AC; Wang X; Chen X
    Biom J; 2006 Dec; 48(6):984-91. PubMed ID: 17240656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Joint hypothesis testing and gatekeeping procedures for studies with multiple endpoints.
    Mascha EJ; Turan A
    Anesth Analg; 2012 Jun; 114(6):1304-17. PubMed ID: 22556210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penalty-based approaches to evaluating multiplicity adjustments in clinical trials: Advanced multiplicity problems.
    Paux G; Dmitrienko A
    J Biopharm Stat; 2018; 28(1):169-188. PubMed ID: 29125802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of hypothesis weights and ordering when testing multiple hypotheses in clinical trials.
    Wiens BL; Dmitrienko A; Marchenko O
    J Biopharm Stat; 2013; 23(6):1403-19. PubMed ID: 24138439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multistage and mixture parallel gatekeeping procedures in clinical trials.
    Dmitrienko A; Kordzakhia G; Tamhane AC
    J Biopharm Stat; 2011 Jul; 21(4):726-47. PubMed ID: 21516566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weighted false discovery rate controlling procedures for clinical trials.
    Benjamini Y; Cohen R
    Biostatistics; 2017 Jan; 18(1):91-104. PubMed ID: 27445132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical planning in confirmatory clinical trials with multiple treatment groups, multiple visits, and multiple endpoints.
    Sun H; Snyder E; Koch GG
    J Biopharm Stat; 2018; 28(1):189-211. PubMed ID: 28992425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gatekeeping procedures in dose-response clinical trials based on the Dunnett test.
    Dmitrienko A; Offen W; Wang O; Xiao D
    Pharm Stat; 2006; 5(1):19-28. PubMed ID: 17080925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.